PT Murni Sadar Tbk (MTMH.JK)
IDR 980.0
(-2.49%)
IDR 980.0
(-2.49%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 224.61 Billion IDR | 2.04% |
| 2022 | 149.35 Billion IDR | 15.8% |
| 2021 | 128.97 Billion IDR | 12.33% |
| 2020 | 114.81 Billion IDR | 1.65% |
| 2019 | 112.95 Billion IDR | 72.19% |
| 2018 | 65.59 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 45.03 Billion IDR | 1.96% |
| 2024 Q2 | 44.16 Billion IDR | 1.18% |
| 2024 Q1 | 43.65 Billion IDR | 2.99% |
| 2023 Q2 | 50.84 Billion IDR | 2.95% |
| 2023 Q3 | 42.56 Billion IDR | -16.29% |
| 2023 Q4 | 42.38 Billion IDR | -0.43% |
| 2023 Q1 | 49.38 Billion IDR | 29.43% |
| 2023 FY | 152.39 Billion IDR | 2.04% |
| 2022 FY | 149.35 Billion IDR | 15.8% |
| 2022 Q4 | 38.15 Billion IDR | -6.0% |
| 2022 Q2 | 29.95 Billion IDR | -26.32% |
| 2022 Q1 | 40.65 Billion IDR | -13.18% |
| 2022 Q3 | 40.59 Billion IDR | 35.54% |
| 2021 Q1 | 25.51 Billion IDR | 0.0% |
| 2021 Q3 | 29.96 Billion IDR | 17.41% |
| 2021 Q2 | 25.51 Billion IDR | -0.0% |
| 2021 FY | 128.97 Billion IDR | 12.33% |
| 2021 Q4 | 46.82 Billion IDR | 56.26% |
| 2020 FY | 114.81 Billion IDR | 1.65% |
| 2019 FY | 112.95 Billion IDR | 72.19% |
| 2018 FY | 65.59 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Bundamedik Tbk | 463.16 Billion IDR | 51.506% |
| PT Metro Healthcare Indonesia Tbk | 125.19 Billion IDR | -79.411% |
| PT Medikaloka Hermina Tbk | 1043.54 Billion IDR | 78.476% |
| PT Mitra Keluarga Karyasehat Tbk | 783.59 Billion IDR | 71.336% |
| PT Famon Awal Bros Sedaya Tbk | 293.68 Billion IDR | 23.518% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -198.541% |
| PT Kedoya Adyaraya Tbk | 105.27 Billion IDR | -113.366% |
| PT Sarana Meditama Metropolitan Tbk | 393.56 Billion IDR | 42.929% |
| PT Siloam International Hospitals Tbk | 2519.46 Billion IDR | 91.085% |
| PT Sejahteraraya Anugrahjaya Tbk | 583.07 Billion IDR | 61.478% |